Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityNo recent work listed

G. Johan A. Offerhaus

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2683-3986; OpenAlex author ID A5036565670. Sources: OpenAlex.

Their work

Papers
15 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
94
Papers, trials and grants by year

2011: 3 papers · 2012: 2 papers · 2013: 2 papers · 2014: 1 paper · 2015: 3 papers · 2016: none · 2017: none · 2018: none · 2019: 2 papers · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 15

  1. Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS-2 multicentre study. Co-author DOI 10.1093/bjs/znac272↗
  2. Amsterdam International Consensus Meeting: tumor response scoring in the pathology assessment of resected pancreatic cancer after neoadjuvant therapy. Co-author DOI 10.1038/s41379-020-00683-9↗
  3. Why is pancreatic cancer so deadly? The pathologist's view. Co-author DOI 10.1002/path.5260↗
  4. Pancreatic cancer organoids recapitulate disease and allow personalized drug screening. Co-author DOI 10.1073/pnas.1911273116↗
  5. Organoid models of human and mouse ductal pancreatic cancer. Co-author DOI 10.1016/j.cell.2014.12.021↗
  6. Diagnostic value of a pancreatic mass on computed tomography in patients undergoing pancreatoduodenectomy for presumed pancreatic cancer. Co-author DOI 10.1016/j.surg.2015.03.008↗
  7. Pancreatic adenocarcinoma pathology: changing "landscape". Co-author DOI 10.3978/j.issn.2078-6891.2015.032↗
  8. Preoperative characteristics of patients with presumed pancreatic cancer but ultimately benign disease: a multicenter series of 344 pancreatoduodenectomies. Co-author DOI 10.1245/s10434-014-3810-7↗
  9. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Co-author DOI 10.1136/gutjnl-2012-303108↗
  10. Pancreatic cancer risk in Peutz-Jeghers syndrome patients: a large cohort study and implications for surveillance. Co-author DOI 10.1136/jmedgenet-2012-101277↗
  11. Multivariate analysis of immunohistochemical evaluation of protein expression in pancreatic ductal adenocarcinoma reveals prognostic significance for persisten… Last author DOI 10.1007/s13402-012-0072-x↗
  12. Pancreatic ductal adenocarcinoma in hereditary diffuse gastric cancer. A case report. Co-author DOI 10.1016/j.humpath.2011.06.008↗
  13. Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation. Co-author DOI 10.1053/j.gastro.2010.11.048↗
  14. mTOR inhibitor treatment of pancreatic cancer in a patient With Peutz-Jeghers syndrome. Co-author DOI 10.1200/jco.2010.32.7825↗
  15. Molecular characteristics of pancreatic ductal adenocarcinoma. Last author DOI 10.4061/2011/620601↗

Closest collaborators

The 25 strongest of 94 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lodewijk A.A. Brosens · 7 shared papers, 2014–2022 · strength 0.50
  2. Ralph H. Hruban MD · 6 shared papers, 2011–2021 · strength 0.34
  3. Marc G. Besselink · 4 shared papers, 2014–2022 · strength 0.27
  4. Izaak Quintus Molenaar · 4 shared papers, 2014–2022 · strength 0.21
  5. Bert A. Bonsing · 4 shared papers, 2011–2022 · strength 0.21
  6. Eline C. Soer · 2 shared papers, 2021–2022 · strength 0.20
  7. Joanne Verheij · 2 shared papers, 2021–2022 · strength 0.20
  8. Seung‐Mo Hong · 2 shared papers, 2019–2021 · strength 0.18
  9. Hans Morreau · 3 shared papers, 2011–2022 · strength 0.17
  10. Laura DeLong Wood · 2 shared papers, 2015–2019 · strength 0.16
  11. Olca Baştürk · 2 shared papers, 2015–2021 · strength 0.12
  12. Mark P.G. Dings · 1 shared paper, 2022 · strength 0.12
  13. Jesse V. Groen · 1 shared paper, 2022 · strength 0.12
  14. Hanneke W.M. van Laarhoven · 1 shared paper, 2022 · strength 0.12
  15. José Annelie Suurmeijer · 1 shared paper, 2022 · strength 0.12
  16. Frederike Dijk · 1 shared paper, 2022 · strength 0.12
  17. Marin Strijker · 1 shared paper, 2022 · strength 0.12
  18. Livia de Guerre · 1 shared paper, 2022 · strength 0.12
  19. Maarten F. Bijlsma · 1 shared paper, 2022 · strength 0.12
  20. Niki A. Ottenhof · 3 shared papers, 2011–2012 · strength 0.10
  21. Sylvia F. Boj · 2 shared papers, 2015–2019 · strength 0.10
  22. Hans C. Clevers · 2 shared papers, 2015–2019 · strength 0.10
  23. Michaël Noë · 1 shared paper, 2019 · strength 0.10
  24. Matthias M. Gaida · 1 shared paper, 2019 · strength 0.10
  25. Roeland F. de Wilde · 3 shared papers, 2011–2012 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.